IVF provider Virtus Health's share price has risen 57% since its low last August and is up 15% since Australia's 9,000 missing babies from 6 Apr 16 (Buy – $6.22). The stock now sports a price-earnings ratio of 17 based on 2016 estimates and a dividend yield of 3.9%. Virtus benefits from economies of scale, has plenty of free cash flow and decent growth prospects, but having brushed past our recommended Buy price, we're downgrading to HOLD.
Note: The Intelligent Investor Growth Portfolio and Equity Income Portfolio own shares in Virtus Health. You can find out about investing directly in Intelligent Investor and InvestSMART portfolios by clicking here.
Disclosure: The author owns shares in Virtus Health.